Daniel H. Shevrin

Evanston Hospital

关注

立即认领

关注

立即认领

基本信息

浏览量：67

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 97 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplemental Figure 2 from Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (Brcaaway)

Maha Hussain,Masha Kocherginsky,Neeraj Agarwal,Nabil Adra,Jingsong Zhang,Channing J. Paller,Joel Picus,Zachery R. Reichert,Russell Z. Szmulewitz,Scott T. Tagawa,Timothy M. Kuzel,Latifa A. Bazzi,Stephanie Daignault-Newton,Young E. Whang,Robert Dreicer,Ryan D. Stephenson,Matthew B. Rettig,Daniel Shevrin,Travis Gerke,Arul M. Chinnaiyan,Emmanuel S. Antonarakis

crossref（2024）

引用0浏览0引用

BRCAAway: A Randomized Phase 2 Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mcrpc) Bearing Homologous Recombination-Repair Mutations (Hrrm)

Maha H. A. Hussain,Masha Kocherginsky,Neeraj Agarwal,Nabil Adra,Jingsong Zhang,Channing Judith Paller,Joel Picus,Zachery R. Reichert,Russell Zelig Szmulewitz,Scott T. Tagawa,Timothy Kuzel,Latifa Bazzi,Stephanie Daignault-Newton,Young E. Whang,Robert Dreicer,Ryan D. Stephenson,Matthew Rettig,Daniel Shevrin,Arul Chinnaiyan,Emmanuel S. Antonarakis

JOURNAL OF CLINICAL ONCOLOGYno. 4_SUPPL (2024): 19-19

引用8浏览0引用

Supplemental Table 4 from Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (Brcaaway)

crossref（2024）

引用0浏览0引用

Supplemental Table 2 from Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (Brcaaway)

crossref（2024）

引用0浏览0引用

Ronald C. Chen,Gina L. Mazza,Briant Fruth,Han Xiao,Joel Picus,Mary Ellen Taplin,Tanya B. Dorff,Leonard Joseph Appleman,Douglas Jay Weckstein,Akash Patnaik,Alan Haruo Bryce,Daniel Shevrin,James L. Mohler,Daniel M. Anderson,Arpit Rao,Alan Tan,Charles J. Ryan,Scott Eggener,Michael J. Morris,Rahul Raj Aggarwal

Journal of Clinical Oncologyno. 16_suppl (2024): 5006-5006

引用0浏览0引用

PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients with High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

Rahul Aggarwal,Glenn Heller,David W. Hillman,Han Xiao,Joel Picus,Mary-Ellen Taplin,Tanya Dorff,Leonard Appleman,Douglas Weckstein,Akash Patnaik,Alan Bryce,Daniel Shevrin,James Mohler,Daniel Anderson,Arpit Rao,Scott Tagawa,Alan Tan,Susan Halabi,Katharine Dooley, Patrick O'Brien,Ronald Chen,Charles J. Ryan,Scott E. Eggener,Michael J. Morris

Journal of Clinical Oncology（2024）

引用5浏览0WOS引用

Supplemental Figure 1 from Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (Brcaaway)

crossref（2024）

引用0浏览0引用

Supplemental Table 1 from Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (Brcaaway)

crossref（2024）

引用0浏览0引用

Supplemental Table 6 from Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (Brcaaway)

crossref（2024）

引用0浏览0引用

Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (Brcaaway)

Clinical Cancer Research (2024)

引用1浏览0WOS引用

加载更多

作者统计

#Papers: 97

#Citation: 6441

H-Index: 26

G-Index: 69

Sociability: 7

Diversity: 3

Activity: 46

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn